Retail Pharmacy with 3 Locations in Austin, Texas
For Sale in TX
Financial & Assets Details
About the Business
All Buyers - Individual(s) or Corporation(s)
Must Provide Resume(s), Proof of Net-Worth, and/or Revenues, Proof of Funds to make the Purchase, and Purchase Plan.
All Buyers are Introduced to the Seller based on the Buyer submission of Information. Approval Granted by the Seller, to the Buyer to Review the Offering Book in Detail.
It is expressed that American Healthcare Capital Does NOT Advise Sellers or Buyers to engage another party with no experience in the Healthcare Industry and/or other industry; and rejects potential sellers or buyers based on lack of industry knowledge a factor in qualification of any seller and/or buyer engagement.
QUALIFIES FOR SBA FINANCING INQUIRE
Growth & Expansion
Each location is fully staffed, and employees are expected to continue working under new ownership. The asking price is $8 Million. The seller is willing to sell a majority percentage of the company on a pro rata basis and participate in a joint venture wherein he provides ongoing, value-added support to the business.
I am pleased to introduce a multi-location, retail, specialty, and compounding pharmacy for sale in the Austin, Texas area. The company has been in business for 7 years. They focus on a wide range of therapies, including hormone replacement, pain management, wound and scar care, sports medicine, dermatology, pediatrics, dentistry, veterinary, erectile dysfunction, palliative care, anti-aging along with nutritional supplements. One of the locations includes both negative and positive ISO class 7 modular clean rooms.
Reason for Selling:
Approximately 91% of their business is walk in and delivery, and 9% of their business is mail order. The company’s revenues were $15.81 Million in 2015 with an adjusted EBITDA of $4.69 Million. In 2016, the company experienced a significant drop in compounding revenue, resulting in year-end total gross revenue of $5.88 Million. For the first two quarters of 2017, the revenue was $4.34 Million with an Adjusted EBITDA $805,000, and their expected run rate is $8.6 Million. The adjusted EBITDA margin is expected to be in the same range or even higher as a result of specific new marketing initiatives.